Ultragenyx Pharmaceutical | RARE - Ebit





Ebit Cambio Fecha
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Kyowa Hakko Kirin JPY 26.41B 4.15B 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
Moderna USD 130M 945M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09